Literature DB >> 3472226

Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6.

M D Lee, A Zentella, W Vine, P H Pekala, A Cerami.   

Abstract

Exposure of fully differentiated L6 myotubes to a crude monokine preparation from endotoxin-stimulated RAW 264.7 cells resulted in a rapid and substantial (70%) increase in fructose 2,6-bisphosphate concentration coincident with a depletion of cellular glycogen and an increased lactate production. During the time required for glycogen depletion (3 hr), stimulation of 3-O-methyl-D-glucose and 2-deoxy-D-glucose uptake was initiated and observed to reach a maximum enhancement of 200% 12-15 hr later. The monokine had no effect on the Km value for 2-deoxy-D-glucose uptake (1.1 mM), while Vmax was increased from 912 to 2400 pmol/min per mg of protein. The increase was cytochalasin B inhibitable and was dependent on protein synthesis. Photoaffinity labeling and equilibrium binding studies with [3H]cytochalasin B support the hypothesis that this increase in hexose transport was due to an increase in hexose transporters present in the plasma membrane. Purified recombinant interleukin-1 alpha had no effect on hexose transport, whereas purified recombinant cachetin/tumor necrosis factor did stimulate hexose uptake, with half-maximal stimulation occurring at 36 nM. Although cachetin accounts for most of the biological activity associated with the crude monokine preparations, it is not the only monokine capable of inducing glucose transport in L6 cells. Specific immunoabsorption of cachectin/tumor necrosis factor from the crude monokine preparation revealed a monokine that had a similar bioactivity at extremely low concentrations on L6 cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472226      PMCID: PMC304703          DOI: 10.1073/pnas.84.9.2590

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Interaction of protein antigens and antibodies. I. Inhibition studies with the egg albumin-antiegg albumin system.

Authors:  W J KLEINSCHMIDT; P D BOYER
Journal:  J Immunol       Date:  1952-09       Impact factor: 5.422

2.  Cloned myogenic cells during differentiation: membrane biochemistry and fine structural observations.

Authors:  T R Podleski; S Nichols; P Ravdin; M M Salpeter
Journal:  Dev Biol       Date:  1979-01       Impact factor: 3.582

3.  Retention of differentiation potentialities during prolonged cultivation of myogenic cells.

Authors:  D Yaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

Review 4.  Gluconeogenesis, ureagenesis, and ketogenesis during sepsis.

Authors:  W R Beisel; R W Wannemacher
Journal:  JPEN J Parenter Enteral Nutr       Date:  1980 May-Jun       Impact factor: 4.016

5.  Insulin binding and glucose transport in rat skeletal muscle sarcolemmal vesicles.

Authors:  G K Grimditch; R J Barnard; S A Kaplan; E Sternlicht
Journal:  Am J Physiol       Date:  1985-10

6.  Tumor necrosis factor (TNF).

Authors:  L J Old
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

7.  Lipopolysaccharide-treated RAW 264.7 cells produce a mediator that inhibits lipoprotein lipase in 3T3-L1 cells.

Authors:  J R Mahoney; B A Beutler; N Le Trang; W Vine; Y Ikeda; M Kawakami; A Cerami
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Studies of insulin resistance in adipocytes induced by macrophage mediator.

Authors:  P Pekala; M Kawakami; W Vine; M D Lane; A Cerami
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.

Authors:  K J Tracey; S F Lowry; B Beutler; A Cerami; J D Albert; G T Shires
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

Review 2.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Lawrence I Grossman; Jeffrey W Doan; Thomas H Sanderson
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase.

Authors:  M D Nawabi; K P Block; M C Chakrabarti; M G Buse
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa.

Authors:  A Schattner; M Steinbock; R Tepper; A Schonfeld; N Vaisman; T Hahn
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

5.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.

Authors:  Y M Fong; M A Marano; L L Moldawer; H Wei; S E Calvano; J S Kenney; A C Allison; A Cerami; G T Shires; S F Lowry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Response of cultured rat Kupffer cells to lipopolysaccharide.

Authors:  H Van Bossuyt; C Desmaretz; B Rombaut; E Wisse
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

7.  Hypoglycemia, hormones and cytokines in fatal meningococcal septicemia.

Authors:  J A Romijn; M H Godfried; C Wortel; H P Sauerwein
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

8.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

9.  Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.

Authors:  S Matsui; A Matsumori; Y Matoba; A Uchida; S Sasayama
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase.

Authors:  Lobelia Samavati; Icksoo Lee; Isabella Mathes; Friedrich Lottspeich; Maik Hüttemann
Journal:  J Biol Chem       Date:  2008-06-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.